HOUSE_OVERSIGHT_024758.jpg

1.38 MB

Extraction Summary

2
People
8
Organizations
1
Locations
2
Events
1
Relationships
1
Quotes

Document Information

Type: Investment report / market analysis
File Size: 1.38 MB
Summary

This document is page 122 of a December 2017 Cannabis Investment Report by Ackrell Capital. It provides a financial summary and stock price performance analysis of U.S. publicly traded cannabis-related companies as of November 2017. The report notes that the election of Donald Trump and the confirmation of Jeff Sessions did not negatively impact the stock performance of these companies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to Congress.

People (2)

Name Role Context
Donald Trump U.S. President
Mentioned in the context of his election not slowing the performance of cannabis stocks.
Jeff Sessions U.S. Attorney General
Mentioned in the context of his confirmation not slowing the performance of cannabis stocks.

Organizations (8)

Name Type Context
Ackrell Capital, LLC
Investment firm issuing the Cannabis Investment Report.
S&P Global Market Intelligence
Cited as the source for market data.
Nasdaq
Listed as a market for cannabis companies.
NYSE
Listed as a market for cannabis companies.
NYSE American
Listed as a market for cannabis companies.
FINRA
Ackrell Capital is listed as a member.
SIPC
Ackrell Capital is listed as a member.
House Oversight Committee
Implied by the Bates stamp 'HOUSE_OVERSIGHT'.

Timeline (2 events)

Early 2017
Jeff Sessions confirmed as U.S. Attorney General
United States
November 2016
Donald Trump elected as U.S. President
United States

Locations (1)

Location Context
Focus of the market analysis.

Relationships (1)

Donald Trump Political Appointment Jeff Sessions
Text mentions 'selection of Jeff Sessions as Attorney General' following Trump's election.

Key Quotes (1)

"As shown in this chart, the election of Donald Trump as President and the selection of Jeff Sessions as Attorney General of the United States have not slowed the continuing positive price performance of cannabis-related companies trading on U.S. markets."
Source
HOUSE_OVERSIGHT_024758.jpg
Quote #1

Full Extracted Text

Complete text extracted from the document (1,911 characters)

ACKRELL
CAPITAL
Cannabis Investment Report | December 2017
Summary of U.S. Publicly Traded Cannabis-Related Companies
(As of November 30, 2017)
Average ($U.S. millions)
Number of Companies
Market Value
Enterprise Value
Cash
Debt
LTM Revenue
LTM EBITDA
Nasdaq
4
$1,033.6
$884.5
$153.6
$4.5
$44.0
-$81.1
NYSE
1
63.5
41.3
22.2
0.0
4.6
-1.2
NYSE American
2
152.1
145.7
7.8
1.4
7.3
-6.5
OTC
212
46.3
65.5
5.7
25.0
14.0
0.2
United States
219
$65.5
$81.2
$8.5
$24.3
$14.5
-$1.4
Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined by S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization.
Stock Price Performance of U.S. Publicly Traded Cannabis-Related Companies
The following chart shows the stock price performance of selected publicly traded cannabis-related companies in the United States since September 30, 2016. As shown in this chart, the election of Donald Trump as President and the selection of Jeff Sessions as Attorney General of the United States have not slowed the continuing positive price performance of cannabis-related companies trading on U.S. markets.
U.S. Cannabis Stock Price Performance
[Chart Graph containing the following labels and axis]
800%
700%
600%
500%
400%
300%
200%
100%
0%
-100%
Sep 16
Nov 16
Jan 17
Mar 17
May 17
Jul 17
Sep 17
Nov 17
[Labels pointing to graph lines]
Sessions confirmed as U.S. Attorney General
Trump elected as U.S. President
[Legend]
S&P 500
Nasdaq/NYSE Cannabis Index
OTC Cannabis Index
Source: S&P Global Market Intelligence
122
© 2017 Ackrell Capital, LLC | Member FINRA / SIPC
HOUSE_OVERSIGHT_024758

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document